HIGHLIGHTS
- who: GUIDELINE et al. from the Department of Clinical Pharmacology, National Institute of Oncology, Chest and Abdominal Tumours Chemotherapy "B", Research Institute, Medical University-Pleven, Pleven, Bulgaria, Oncology Centre, Semmelweis University, Budapest have published the paper: Systemic Treatment of Breast Cancer. 1st Central-Eastern European Professional Consensus Statement on Breast Cancer, in the Journal: (JOURNAL)
- what: PRIMARY SYSTEMIC TREATMENT OF INFLAMMATORY BREAST CANCER (T4D) From the clinical standpoint, the primary objective of the treatment of inflammatory breast cancer is to transform a primary unresectable tumour into a resectable one.
- how: This trial also . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.